Vanguard Group Inc Agios Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,496,737 shares of AGIO stock, worth $253 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,496,737
Previous 5,572,021
1.35%
Holding current value
$253 Million
Previous $163 Million
45.48%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.2MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$261 Million1.18% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$224 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$179 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$128 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.2MShares$101 Million0.03% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.53B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...